Skip Navigation
 
 
 
 xxx
 
Print This Page
Share this page: More
 

By Cancer Type

 

Acute Lymphoblastic Leukemia

Survivors may experience the following late effects, depending on their treatment(s):

  • cardiovascular disease (including congestive heart failure, infection of the heart sac, and arrhythmias)
  • bladder damage
  • kidney damage
  • liver damage
  • lung damage
  • hormonal imbalances
  • reduced fertility or infertility in men and women
  • osteonecrosis, or bone death
  • higher risk of obesity
  • elevated cholesterol levels
  • hepatitis B and C (see "Blood Transfusion" for more information)
  • cognitive and learning difficulties ("chemo brain")
  • slow growth
  • secondary cancers
  • depression and other psychological disorders

Acute Myeloid Leukemia

Acute myeloid leukemia survivors may experience the following late effects, depending on their treatment(s):

  • cardiovascular disease (including congestive heart failure, infection of the heart sac, and heart arrhythmias)
  • bladder damage
  • kidney damage
  • liver damage
  • hormonal imbalances
  • reduced fertility or infertility in men and women
  • bone death (osteonecrosis)
  • earning, memory, and cognition difficulties ("chemo brain")
  • hearing loss
  • hepatitis B and C (see "Blood Transfusion" for more information)
  • secondary cancers
  • depression and other psychological disorders

Chronic Myeloid Leukemia

Chronic myeloid leukemia survivors may experience the following late effects, depending on their treatment(s):

  • cardiovascular disease (including congestive heart failure, infection of the heart sac, and heart arrhythmias)
  • reduced fertility or infertility in men and women
  • lung damage
  • kidney damage
  • bladder damage
  • liver damage
  • learning, memory, and cognition difficulties ("chemo brain.")
  • hepatitis B and C (see "Blood Transfusion" for more information)
  • secondary cancers
  • depression and other psychological disorders

Chronic Lymphocytic Leukemia

Chronic lymphocytic leukemia survivors may experience the following late effects, depending on their treatment(s):

  • cardiovascular disease (including congestive heart failure, infection of the heart sac, and heart arrhythmias)
  • reduced fertility or infertility in men and women
  • elevated cholesterol levels
  • higher risk of obesity
  • kidney damage
  • bone death (osteonecrosis)
  • learning, memory, and cognition difficulties ("chemo brain.")
  • hepatitis B and C (see "Blood Transfusion" for more information)
  • secondary cancers
  • depression and other psychological disorders

Myelodysplastic Syndrome

Myelodysplastic syndrome survivors may experience the following late effects, depending on their treatment(s):

  • cardiovascular disease (including congestive heart failure, infection of the heart sac, and heart arrhythmias)
  • reduced fertility or infertility in men and women
  • bladder damage
  • kidney damage
  • hepatitis B and C (see "Blood Transfusion" for more information)
  • secondary cancers
  • depression and other psychological disorders

Myeloproliferative Disorder

Myeloproliferative disorder survivors may experience the following late effects, depending on their treatment(s):

  • cardiovascular disease (including congestive heart failure, infection of the heart sac, and heart arrhythmias)
  • reducedfertility or infertility in men and women
  • bladder damage
  • kidney damage
  • liver damage
  • learning, memory, and cognition difficulties ("chemo brain")
  • hepatitis B and C (see "Blood Transfusion" for more information)
  • secondary cancers
  • depression and other psychological disorders
 

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

Maryland 410-955-5222
U.S. 410-955-5222
International +1-410-614-6424

NCI CCC

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer